STAT1 gain-of-function disease

Clinical trials for STAT1 gain-of-function disease explained in plain language.

Never miss a new study

Get alerted when new STAT1 gain-of-function disease trials appear

Sign up with your email to follow new studies for STAT1 gain-of-function disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Experimental drug offered to single patient with rare immune disease

Disease control Expanded access

This expanded access program provides itacitinib, an experimental drug, to one patient with STAT1 gain-of-function disease who also has aplastic anemia. The goal is to control the overactive immune system and manage the disease. This is not a cure, and the patient will likely nee…

Matched conditions: STAT1 GAIN-OF-FUNCTION DISEASE

Sponsor: Incyte Corporation • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

STAT1 gain-of-function disease

Get alerted when new STAT1 gain-of-function disease trials appear

Experimental drug offered to single patient with rare immune disease